Hill-Rom beds subject of MHRA (Medicines and Healthcare products Regulatory Agency) alert:
This article was originally published in Clinica
Hill-Rom, of Batesville, Indiana, is the subject of a device alert by the UK's Medicines and Healthcare products Regulatory Agency (MHRA), following problems with its Evolution 150BO electric beds. On April 14, Hill-Rom announced restructuring plans thatwill see up to 300 salaried jobs from its current total of 6,100 cut over the next 12 months, while taking on some 100 sales staff. "The next phase of our strategy [is] greater emphasis on new revenue growth," said Frederick Rockwood, president and CEO of Hill-Rom's parent company, Hillenbrand Industries. Hill-Rom reported revenues of $1.2bn in the year to September 30 2002. "The new structure will improve our ability to integrate possible future acquisitions," said Hill-Rom president and CEO R Ernest Waaser. Faults in devices fitted with an SKF head-end actuator have resulted in the bed being unable to adopt - even manually - the cardio-pulmonary resuscitation (CPR) position when the head-end electric motor is turned off. 3,445 such beds have been sold in the UK since June 2001. Hill-Rom claims to be aware of problems in a "small percentage of production", says the MHRA, but one UK National Health Service hospital reported that 11 of its 17 Evolution 150BOs were affected.